Transcription
29th AnnualCardiovascular Interventions 2018October 23-26, 2018Hilton La Jolla Torrey PinesLa Jolla, CACourse Director:Paul S. Teirstein, MD, DNBPAS, FACC, FSCAIScripps Course Co-Directors:Matthew J. Price, MD, FACC, FSCAIRichard A. Schatz, MD, FACCCurtiss T. Stinis, MD, FACC, FSCAI
COURSE OVERVIEWCardiologists are trained during their fellowship years in the latest techniques, technologies,standards of practice and guidelines for patient care. However, the practice of medicine changesrapidly and the discipline of interventional cardiology changes dramatically each year. Changesin interventional cardiology directly impact patient care and require constant updates tophysician knowledge and practices. Physicians rely on journal articles, interaction withcolleagues and lectures throughout the year to keep their knowledge up-to-date. The primarypurpose of the “29th Annual Cardiovascular Interventions” symposium is to provide thepracticing physician and cardiovascular care team with a concentrated exposure to newdevelopments in interventional cardiology that will positively influence patient outcomes.The 2018 scientific program has been carefully designed by consulting recent key clinical trialdata, articles in peer-reviewed scientific journals, physician focus groups, past evaluations, andneeds assessments. By attending this program, participants will learn the latest advances anddebates in interventional cardiology. They will return to their practice environment armed withthe latest evidence-based, practical information to improve patient care and outcomes.EDUCATIONAL OBJECTIVESAfter attending this educational activity, participants should be able to: Apply new technical approaches to specific lesion subsets such as bifurcation lesions, leftmain lesions, chronic total occlusions and saphenous vein graft disease Integrate the latest guidelines and practice improvements into the management ofmyocardial function Discuss new techniques under development for percutaneous cardiac valve repair andreplacement Reduce common catheterization laboratory patient complications using new techniquesand technologies Critique the latest evidence supporting new cardiac imaging modalities such as IVUS,OCT and FFR guided stent deployment Prescribe the appropriate antithrombotic therapies based on the latest data and guidelines
TARGET AUDIENCEThis course is designed for interventional cardiologists, cardiac surgeons, vascular surgeons,internists, nurses, cath lab technicians, perfusionists, registered cardiovascular invasive specialists,radiologic techologists, and those with a special interest in interventional cardiology. No experiencein interventional cardiology is required, however a basic understanding of the field is recommended.FACULTY DISCLOSURESIn accordance with the ACCME Standards for Commercial Support, course directors, planningcommittees, faculty and all others in control of the educational content of the CME activity mustdisclose all relevant financial relationships with any commercial interest that they or theirspouse/partner may have had within the past 12 months. If an individual refuses to disclose relevantfinancial relationships, they will be disqualified from being a part of the planning andimplementation of this CME activity. Employees of a commercial interest with business lines orproducts relating to the content of the CME activity will not participate in the planning orimplementation of the accredited portions of the symposium. Individual disclosures will be made toall participants at the conference location prior to the educational activity commencement and areavailable in the online syllabus.ONLINE SYLLABUSSlides presented during the accredited portions of the symposium (when approved by thespeaker), along with all meeting reference materials are available online . Approved slides will be posted online asPDFs within 24 hours of presentation.RADIATION SAFETYThis conference fulfills the Title 17 California Code requirement for 4 CE credits in radiationsafety for the clinical uses of fluoroscopy.Radiation safety materials have been included in the online syllabus for your reference .
CME ACCREDITATION & DESIGNATIONPhysicians & Physician AssistantsPromedica International is accredited by the Accreditation Council for ContinuingMedical Education (ACCME) to provide continuing medical education for physicians.Promedica International designates this live activity for a maximum of 23 AMA PRACategory 1 Credits . Physicians should claim only the credit commensurate with theextent of their participation in the activity.NursesProvider approved by the California Board of Registered Nursing, Provider #8495 for 23 ContactHours.PerfusionistsThe American Board of Cardiovascular Perfusion (ABCP) has approved a total of 27.6 Category1 CEUs for perfusionists for Wednesday, October 24 (4.8), Thursday, October 25 (11.4), andFriday, October 26 (11.4).Radiologic TechnologistsThe “Cardiovascular Interventions” symposium has been approved by the ASRT for Category Acontinuing education credit. Each session is accredited individually, detailed below. Wednesday, Oct 24 – 1:30 – 3:30 PM Session (2.25 Category A Credits)Wednesday, Oct 24 – 4:00 – 6:00 PM Session (2.25 Category A Credits)Thursday, Oct 25 – 7:30 – 9:30 AM Session (2.25 Category A Credits)Thursday, Oct 25 – 10:00 AM – 12:00 PM Session (2.25 Category A Credits)Thursday, Oct 25 – 12:00 – 1:30 PM Session (1.75 Category A Credits)Thursday, Oct 25 – 1:30 – 3:30 PM Session (2.25 Category A Credits)Thursday, Oct 25 – 4:00 – 6:00 PM Session (2.25 Category A Credits)Friday, Oct 26 – 7:30 – 9:30 AM Session (2.25 Category A Credits)Friday, Oct 26 – 10:00 AM – 12:00 PM Session (2.25 Category A Credits)Friday, Oct 26 – 12:00 – 1:30 PM Session (1 Category A Credit)Friday, Oct 26 – 1:30 – 3:30 PM Session (2.25 Category A Credits)Friday, Oct 26 – 4:00 – 6:00 PM Session (2.25 Category A Credits)
Registered Cardiovascular Invasive Specialists (RCIS)CCI does not approve CEUs directly however CCI will accept CEUs that have already beenapproved by accredited sponsors of the Accreditation Council for Continuing Medical Education(ACCME). RCIS attendees will claim the physician certificate option when completing theonline evaluation and can use that certificate to claim CEUs from CCI.ABIM MOC POINTSSuccessful completion of this CME activity, which includes participation inthe evaluation component, enables the participant to earn up to 23 MedicalKnowledge MOC points and Patient Safety MOC credit in the AmericanBoard of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participantswill earn MOC points equivalent to the amount of CME credits claimed for the activity. It is theCME activity provider’s responsibility to submit participant completion information to ACCME forthe purpose of granting ABIM MOC credit.Please keep in mind the following dates when claiming your MOC points:Physicians claiming MOC points for their participation in the symposium must complete theonline program evaluation by December 14, 2018 in order for the MOC points to count towardany MOC requirements that are due by the end of 2018.Evaluations received after December 14, 2018 and before March 15, 2019 will continue to bereported to ABIM and any ABIM Board Certified physician who experienced a negative statuschange as a direct result of insufficient MOC points will have their status adjusted once therequired points have been earned.If you need the MOC points to count for your 2018 record, please be sure tosubmit your evaluation by December 14, 2018. MOC points will not beavailable for this course after March 15, 2019.CLAIMING YOUR CME/CE CERTIFICATE1.2.3.4.Visit https://promedicacme.com/ and scroll downIn the Past CME Symposia section, click “Take Evaluation” by the CI 2018 iconComplete the appropriate program evaluationYour CME certificate will be emailed to you within 2 weeks of submissionPlease note the following:*Physicians will also be able to claim ABIM MOC points for 2018 via the online evaluation form throughDecember 14, 2018.
EDUCATIONAL GRANTSThis program is supported, in part, by educational grants from industry, inaccordance with the ACCME’s Standards for Commercial Support.We gratefully acknowledge and thank the following contributors who have givengenerously to support this symposium.AbbottAbiomed, Inc.AstraZenecaBIOTRONIK, Inc.Boston ScientificCardiovascular Systems, Inc.Chiesi USA, Inc.Edwards LifesciencesMedtronicPhilips
EXHIBITS, PROMOTIONAL &SATELLITE SYMPOSIA ACKNOWLEDGEMENTSAbbottAbiomed, Inc.ACIST Medical Systems, Inc.AmgenAsahi Intecc USAAstraZenecaBD(Formerly Bard Peripheral Vascular)Boston ScientificCardiovascular Systems, Inc.Chiesi USA, Inc.Cook MedicalCordis, a Cardinal Health CompanyEdwards LifesciencesGE Healthcare
GileadGore & AssociatesHeartFlowJanssen Pharmaceuticals, Inc.Medicure PharmaMedtronicNational Board of Physicians and Surgeons (NBPAS)Opsens MedicalOstial CorporationPhilipsPreventice SolutionsSanofiTeleflexTerumo Interventional Systems
COURSE DIRECTORPaul S. Teirstein, MD, DNBPAS, FACC, FSCAIChief of CardiologyDirector, Interventional CardiologyScripps ClinicDirector, Scripps Prebys Cardiovascular InstituteScripps HealthLa Jolla, CASCRIPPS COURSE CO-DIRECTORSMatthew J. Price, MD, FACC, FSCAIDirector, Cardiac Catheterization LaboratoryScripps ClinicAssistant ProfessorScripps Translational Science InstituteLa Jolla, CARichard A. Schatz, MD, FACCResearch Director, Cardiovascular InterventionsDirector, Gene and Cell TherapyScripps ClinicLa Jolla, CACurtiss T. Stinis, MD, FACC, FSCAIDirector, Peripheral InterventionsDirector, Interventional Cardiology Fellowship ProgramScripps ClinicLa Jolla, CA
SYMPOSIUM FACULTYZiad Ali, MD, DPhilAssistant Professor of MedicineDirector, Intravascular Imaging and PhysiologyDirector, Cardio-Renal ProgramColumbia University Medical CenterNew York Presbyterian HospitalDirector, Angiographic Core LaboratoryCardiovascular Research FoundationNew York, NYDaniel Burkhoff, MD, PhDDirector, Heart Failure, Hemodynamics and MCS ResearchCardiovascular Research FoundationNew York, NYJorge A. Gonzalez, MD, FACC, FSCMRDirector, Advanced Cardiovascular Imaging (CT/MRI)Co-Director, Hypertrophic Cardiomyopathy ClinicDirector, Aortic Imaging ClinicScripps Clinic Division of Cardiovascular DiseasesScripps Clinic Division of RadiologyLa Jolla, CAJ. Aaron Grantham, MD, FACC, FSCAIAssociate Professor of MedicineConsulting CardiologistSaint Luke’s Mid America Heart InstituteKansas City, MissouriCindy Grines, MD, FACC, FSCAIChair Interim - Cardiology DepartmentNorth Shore University HospitalAcademic Chair of CardiologyHofstra Northwell School of MedicineManhasset, NYJames Hermiller, MD, FACC, MSCAIDirector, Interventional CardiologyDirector, Interventional Cardiology FellowshipSt. Vincent Heart CenterIndianapolis, IN
Amir Kaki, MD, FACC, FSCAIMedical Director, Cardiac Cath LabDMC Heart HospitalDetroit, MIDean Kereiakes, MD, FACCMedical DirectorThe Christ Hospital Heart and Vascular CenterThe Carl and Edyth Lindner Center for Research and EducationThe Christ HospitalCincinnati, OHMorton Kern, MD, MSCAI, FACC, FAHAChief of MedicineVA Long Beach Health Care SystemLong Beach, CAProfessor of MedicineUniversity of California, IrvineOrange, CAEric Lindley, MD, FACCInterventional CardiologyMcKay-Dee HospitalOgden, UTEhtisham Mahmud, MD, FACC, FSCAIDivision Chief, Cardiovascular MedicineExecutive Director, Sulpizio Cardiovascular CenterUC San DiegoSan Diego, CARajan Patel, MD, FACC, FAHA, FSCAISenior Lecturer, Interventional CardiologyOchsner Clinical SchoolUniversity of QueenslandOchsner Health SystemNew Orleans, LAAshish Pershad, MD, FACC, FSCAIDirector of Cardiac Catheterization LaboratoryBanner University Medical CenterPhoenix, AZ
Duane S. Pinto, MD, MPH, FACC, FSCAIAssociate Professor of MedicineHarvard Medical SchoolChief, Interventional CardiologyDirector, Cardiac Intensive Care UnitBeth Israel Deaconess Medical CenterBoston, MADanny Ramzy, MD, PhD, FACCDirector, Robotic and Minimally Invasive Cardiac SurgeryCedars-Sinai Medical CenterLos Angeles, CADavid Rizik, MD, FACC, MSCAIChief Scientific OfficerDirector of Structural and Coronary InterventionsHonorHealth Heart GroupScottsdale, AZRobert Safian, MD, FACC, FSCAIDirector, Center for Innovation and Research in Cardiovascular DiseasesBeaumont HealthRoyal Oak, MIJacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAIClinical ProfessorVancouver General HospitalVancouver, CanadaAjay Srivastava, MD, FACCDirector, Acute Mechanical Circulatory Support ProgramScripps ClinicLa Jolla, CARaj Sugumaran, MD, FACC, FSCAICardiac SolutionsBanner HealthPhoenix, AZDouglas Triffon, MD, FACC, FNLADirector of the Lipid Disorders ClinicScripps ClinicLa Jolla, CA
Robert Wilson, MDProfessorUniversity of MinnesotaCSIOACIST Medical SystemsMinneapolis, MNGeorge W. Vetrovec, MD, MACC, MSCAIProfessor EmeritusVirginia Commonwealth UniversityRichmond, Virginia
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSIn accordance with the Accreditation Council for Continuing Medical Education’s Standards for CommercialSupport, all course director(s), presenters, moderators, planners, and peer reviewers involved in the development ofCME content are required to disclose to the accredited provider any relevant financial relationships of themselvesand their spouse/partner via a Disclosure of Relevant Financial Relationships form.The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within thepast 12 months that create a conflict of interest. Conflicts of interest must be resolved for the individual to continueparticipation. All participants declare the following: They will comply with the ACCME Standards for Commercial Support of Continuing Medical Educationto ensure that this CME activity is free of commercial bias or appearance thereof.They will base all clinical recommendations on evidence that is accepted within the profession of medicineas adequate justification in the case of patients.They will ensure that all scientific research referred to in support of a patient care recommendation willconform to generally accepted standards of experimental design, data collection, and analysis.They will not discuss any unlabeled uses of products.Failure to return the Disclosure of Relevant Financial Relationships form prior to the beginning of the CME activityresults in disqualification from participation in any development or presentation.DISCLOSURESCourse Director:Paul S. Teirstein, MD, FACC, FSCAISpeaker fees; Consultant: Abbott, Abiomed, Inc., ACIST Medical, Inc., Boston Scientific, MedtronicCourse Co-Directors:Matthew J. Price, MD, FACC, FSCAINothing to discloseRichard A. Schatz, MD, FACCNothing to discloseCurtiss T. Stinis, MD, FACC, FSCAIConsultant: Abbott Vascular, Cook Medical, Edwards Lifesciences, MedtronicInvited Faculty:Ziad Ali, MD, DPhilGrant, Advisory Board, Consultant, Speaker: St. Jude Medical, Boston ScientificConsultant, Speaker: ACIST MedicalJorge A. Gonzalez, MD, FACC, FSCMRHonoraria: Boston Scientific, HeartFlowJ. Aaron Grantham, MD, FACC, FSCAIGrant, Consultant: Abbott Vascular, Boston Scientific, Asahi Intecc,
Cindy L. Grines, MD, FACC, FSCAIAdvisory Board: Abbott Vascular, VolcanoHonoraria: Abiomed, Inc.James Hermiller, MD, FACC, FSCAIConsultant: Edwards Lifesciences, Medtronic, Abbott Vascular, Boston ScientificDean Kereiakes, MD, FACCConsulting Fees: Boston Scientific, Abbott Vascular, SINO Medical Sciences Technologies, Svelte Medical Systems,Inc., Micell Technologies, Inc., Caliber TherapeuticsMajor Stock Shareholder: Ablative Solutions, Inc.Morton Kern, MD, MSCAI, FACC, FAHASpeaker: Abbott/St. Jude, ACIST Medical, HeartFlow, Philips VolcanoEhtisham Mahmud, MD, FACC, FSCAIResearch: CorindusSpeakers Bureau, Research: Abbott VascularSpeakers Bureau: MedtronicResearch: CSIDavid Rizik, MD, FACC, FSCAIMedical Advisory Board: Abbott Vascular, BIOTRONIK, Cordis, A Cardinal Health CompanyExecutive Physician Council; Grant/Research Support; Consulting/Proctor: License Fees/Royalties:Boston ScientificJacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAIResearch: Canadian Institutes of Health Research, University of British Columbia Division of Cardiology, Heart andStroke Foundation, AstraZeneca, Abbott Vascular and ServierConsult/Advisory Board: Abbott Vascular, AstraZeneca, BayerSpeaker Honoraria: AstraZeneca, Bayer, and SunovionAjay Srivastava, MD, FACCSpeaker: Abbott, Abiomed, Inc.Douglas Triffon, MD, FACC, FNLASpeaker’s Bureau: Sanofi, Amgen, Janssen, AmarinPlanner DisclosuresRebecca LawNothing to discloseLaurel SteigerwaldNothing to discloseThe following faculty speakers are only participating during portions of the activity that are not accreditedand will take place in a room separate from the main scientific sessions.Daniel Burkhoff, MD, PhD, Amir Kaki, MD, FACC, FSCAI, Eric Lindley, MD, FACC,Rajan Patel, MD, FACC, FAHA, FSCAI, Ashish Pershad, FACC, FSCAI,Duane S. Pinto, MD, MPH, FACC, FSCAI, Danny Ramzy, MD, PhD, Raj Sugumaran, MD, FACC, FSCAI
Each session is accredited individually, detailed below. Wednesday, Oct 24 - 1:30 - 3:30 PM Session (2.25 Category A Credits) Wednesday, Oct 24 - 4:00 - 6:00 PM Session (2.25 Category A Credits)
